Drug Profile
Dopastatin second generation
Alternative Names: BIM 065Latest Information Update: 28 Sep 2018
Price :
$50
*
At a glance
- Originator Ipsen
- Class Antineoplastics; Catecholamines; Cyclic peptides; Pancreatic hormones; Small molecules
- Mechanism of Action Adrenergic receptor agonists; Corticotropin releasing hormone inhibitors; Dopamine D1 receptor agonists; Growth hormone releasing factor agonists; Growth hormone-releasing hormone inhibitors; Somatostatin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acromegaly; Pituitary ACTH hypersecretion; Pituitary cancer
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for phase-I development in Acromegaly in France (Parenteral)
- 28 Sep 2018 No recent reports of development identified for phase-I development in Pituitary-ACTH-Hypersecretion in France (Parenteral)
- 28 Sep 2018 No recent reports of development identified for phase-I development in Pituitary-cancer in France (Parenteral)